These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28935078)

  • 1. Bioresorbable Vascular Scaffold Implantation: To Whom and How?
    Sabaté M
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1865-1866. PubMed ID: 28935078
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Kozel M; Robert P; Hajšl M; Jarkovský J; Widimský P
    Int J Cardiol; 2016 Apr; 209():20-1. PubMed ID: 26878467
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term.
    Moscarella E; Campo G; Leoncini M; Geraci S; Nicolini E; Cortese B; Loi B; Guiducci V; Saccà S; Varricchio A; Vicinelli P; De Candia G; Silvestro A; Calabrò P; Brugaletta S; Latib A; Tespili M; Ielasi A
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):278-280. PubMed ID: 35287160
    [No Abstract]   [Full Text] [Related]  

  • 6. Subacute thrombosis after primary percutaneous coronary intervention with bioresorbable vascular scaffold implantation.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A
    Kardiol Pol; 2015; 73(4):300. PubMed ID: 25892264
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-Eluting Resorbable Magnesium Scaffold Implantation in ST-Segment Elevation Myocardial Infarction: A Pilot Study.
    de Hemptinne Q; Picard F; Briki R; Awada A; Silance PG; Dolatabadi D; Debbas N; Unger P
    J Invasive Cardiol; 2018 Jun; 30(6):202-206. PubMed ID: 29656279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study.
    Chakraborty R; Patra S; Banerjee S; Pande A; Khan A; Mandol PC; Ghosh D; De SK; Das SS; Nag R
    Cardiovasc Revasc Med; 2016; 17(3):151-4. PubMed ID: 26905052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Scaffold Neovascularization 24 Months After Bioresorbable Vascular Scaffold Implantation in a Patient With ST-Segment Elevation Myocardial Infarction.
    Tomaniak M; Kochman J; Kołtowski Ł; Pietrasik A; Rdzanek A; Filipiak KJ; Opolski G; Regar E
    JACC Cardiovasc Interv; 2017 Jul; 10(13):e123-e125. PubMed ID: 28624381
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
    Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
    Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study.
    Fam JM; Felix C; van Geuns RJ; Onuma Y; Van Mieghem NM; Karanasos A; van der Sijde J; De Paolis M; Regar E; Valgimigli M; Daemen J; de Jaegere P; Zijlstra F; Diletti R
    EuroIntervention; 2016 May; 12(1):30-7. PubMed ID: 27173859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
    Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment elevation myocardial infarction – ideal scenario for bioresorbable vascular scaffold implantation?
    Scalone G; Brugaletta S; Gómez-Monterrosas O; Otsuki S; Sabate M
    Circ J; 2015; 79(2):263-70. PubMed ID: 25744740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Evidence of Complete Resorption 4 Years After Bioresorbable Scaffold Implantation in the Setting of ST-Segment Elevation Myocardial Infarction.
    Gori T; Münzel T
    JACC Cardiovasc Interv; 2017 Jan; 10(2):200-202. PubMed ID: 28040446
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the place of bioresorbable vascular scaffolds in setting of ST-segment elevation myocardial infarction?].
    Lattuca B; Schmutz L; Ledermann B; Cornillet L; Messner-Pellenc P; Leclercq F; Cayla G
    Ann Cardiol Angeiol (Paris); 2015 Dec; 64(6):499-504. PubMed ID: 26482633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a review of currently available clinical data.
    Buccheri D; Piraino D; Chirco PR; Cortese B
    Minerva Cardioangiol; 2016 Feb; 64(1):74-83. PubMed ID: 26447989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Ortega-Paz L; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Giacchi G; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    Int J Cardiol; 2016 Jul; 214():483-4. PubMed ID: 27096965
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).
    Moscarella E; Ielasi A; Varricchio A; De Angelis MC; Loi B; Tarantini G; Calabrò P; Cortese B; Mazzarotto P; Gabrielli G; Pisano F; Facchin M; Misuraca L; Lucci V; Gistri R; Tumminello G; Moretti L; Colombo A; Durante A; Fineschi M; Piraino D; Ferrario M; Coscarelli S; Nicolino A; Tespili M; Corrado D; Steffenino G
    Int J Cardiol; 2018 May; 258():50-54. PubMed ID: 29429635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report.
    Karanasos A; Muramatsu T; Diletti R; Nauta S; Onuma Y; Lenzen M; Nakatani S; Van Mieghem NM; Schultz C; De Jaegere PP; Serruys PW; Zijlstra F; Regar E; van Geuns RJ
    Hellenic J Cardiol; 2015; 56(2):125-35. PubMed ID: 25854441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.